Trinity Biotech (TRIB) Non-Current Assets (2016 - 2025)
Trinity Biotech's Non-Current Assets history spans 17 years, with the latest figure at $69.3 million for Q4 2025.
- On a quarterly basis, Non-Current Assets rose 11.42% to $69.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $69.3 million, a 11.42% increase, with the full-year FY2025 number at $69.3 million, up 11.42% from a year prior.
- Non-Current Assets hit $69.3 million in Q4 2025 for Trinity Biotech, up from $66.6 million in the prior quarter.
- Over the last five years, Non-Current Assets for TRIB hit a ceiling of $69.3 million in Q4 2025 and a floor of $19.1 million in Q2 2023.
- Historically, Non-Current Assets has averaged $44.9 million across 5 years, with a median of $47.0 million in 2021.
- Biggest five-year swings in Non-Current Assets: tumbled 61.78% in 2023 and later soared 204.82% in 2024.
- Tracing TRIB's Non-Current Assets over 5 years: stood at $46.2 million in 2021, then fell by 1.67% to $45.4 million in 2022, then plummeted by 55.11% to $20.4 million in 2023, then soared by 204.82% to $62.2 million in 2024, then increased by 11.42% to $69.3 million in 2025.
- Business Quant data shows Non-Current Assets for TRIB at $69.3 million in Q4 2025, $66.6 million in Q2 2025, and $62.2 million in Q4 2024.